铁木制药 IRWD
$4.39 +$0.36 (+8.93%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $4.36 -0.68%
开盘$4.26
昨收$4.03
当日区间$4.10 – $4.44
成交量3.96M
市值$726.77M
市盈率（TTM）4.9
股息率–
IRWD 相关新闻
匹配 Ironwood Pharmaceuticals 或代码 IRWD 的头条新闻，按最新排序。
- Ironwood Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
- Ironwood Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DENNER ALEXANDER J
- Ironwood Pharmaceuticals' Earnings Call Highlights LINZESS Surge 正面
- 10-Q: Ironwood Pharmaceuticals | 10-Q: Q2 2026 Earnings Report
- Ironwood Pharmaceuticals Q2 Adj. EPS $0.31 Misses $0.36 Estimate, Sales $113.041M Miss $114.844M Estimate 负面
- Ironwood Pharmaceuticals Reports Mixed Q2 Results; Raises FY26 Outlook 正面
- Ironwood Pharmaceuticals | SCHEDULE 13G/A: Others
- Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
- Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $5
- Analysts' Top Healthcare Picks: Ironwood Pharma (IRWD), Sionna Therapeutics, Inc. (SION)
- OneMedNet Collaborates With Inka Health To Provide Access To U.S. Real‐World Oncology Data Via IRWD Platform Powered By Palantir Foundry
- Ironwood Pharmaceuticals(IRWD.US) Director Sells US$20.53 Million in Common Stock
- Citizens JMP Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Raises Target Price to $10 正面
- Ironwood Pharmaceuticals | SCHEDULE 13G/A: Others
- Ironwood Pharmaceuticals Appoints Tammi Gaskins CEO, Effective Jan. 1, 2027
暂无评论——快来第一个聊聊 IRWD。